- JP-listed companies
- FRONTEO,Inc.
- Financials
- FCF margin (%)
FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | FCF margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 11 | -45.98% |
| Mar 31, 2024 | 20.3 | -235.33% |
| Mar 31, 2023 | -15 | -170.96% |
| Mar 31, 2022 | 21.2 | +11.69% |
| Mar 31, 2021 | 19 | -548.35% |
| Mar 31, 2020 | -4.2 | -199.52% |
| Mar 31, 2019 | 4.2 | -59.58% |
| Mar 31, 2018 | 10.5 | -323.77% |
| Mar 31, 2017 | -4.7 | +767.32% |
| Mar 31, 2016 | -0.5 | -104.14% |
| Mar 31, 2015 | 13.1 |